Literature DB >> 22149971

Binding antibody responses to the immunogenic regions of viral envelope in HIV-1-infected Indian children.

S S Prakash1, Raiees Andrabi, Rajesh Kumar, S K Kabra, Rakesh Lodha, Madhu Vajpayee, Kalpana Luthra.   

Abstract

Limited information exists on the antibody responses elicited against the viral envelope in HIV-1-infected children. In this cross-sectional study, we assessed the antibody responses against three different immunogenic regions of HIV-1 envelope, namely V3 region of gp120, membrane proximal external region (MPER), and immunodominant loop (IDL) of gp41 in HIV-1-infected children from north India. We recruited 75 HIV-1-infected (40 antiretroviral naive and 35 treated) children, with age ranging from 1.5 to 16 y. Antibodies to V3 and the IDL region were found in a majority of the infected children, whereas antibodies to MPER were found in approximately one-third of the children studied. Higher antibody titers to the immunogenic regions corresponded to the symptomatic stages of HIV-1 infection in both naive and antiretroviral therapy (ART)-treated children. High titers of anti-V3C and anti-IDL antibodies were observed in a subset of antiretroviral-naive patients with suppressed viremia (<47 RNA copies/mL), suggesting that antibodies to these immunogenic regions are present regardless of their viremic status. Further, the antibody titers were significantly lower in the plasma of treated patients compared to naive patients, regardless of whether they were virologically suppressed or not. This is the first report on the antibody responses elicited in HIV-1-infected children in India. The study may help to understand the humoral antibody responses directed against viral envelope in HIV-1-infected children.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22149971      PMCID: PMC3234704          DOI: 10.1089/vim.2011.0039

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  21 in total

1.  Characterization of the HIV-1 specific humoral immune response during highly active antiretroviral therapy (HAART).

Authors:  M K Morris; D A Katzenstein; D Israelski; A Zolopa; R M Hendry; C V Hanson
Journal:  J Acquir Immune Defic Syndr       Date:  2001-12-15       Impact factor: 3.731

2.  Efficient neutralization of primary isolates by the plasma from HIV-1 infected Indian children.

Authors:  S S Prakash; Alok Kumar Chaudhary; Rakesh Lodha; S K Kabra; Madhu Vajpayee; Anjali Hazarika; Barun Bagga; Kalpana Luthra
Journal:  Viral Immunol       Date:  2011-10       Impact factor: 2.257

3.  Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus.

Authors:  J W Gnann; J A Nelson; M B Oldstone
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

4.  Association of antibody reactivity to ELDKWA, a glycoprotein 41 neutralization epitope, with disease progression in children perinatally infected with HIV type 1.

Authors:  R B Geffin; G B Scott; M Melenwick; C Hutto; S Lai; L J Boots; P M McKenna; J A Kessler; A J Conley
Journal:  AIDS Res Hum Retroviruses       Date:  1998-05-01       Impact factor: 2.205

5.  Children born to women with HIV-1 infection: natural history and risk of transmission. European Collaborative Study.

Authors: 
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

6.  Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children.

Authors:  P E Palumbo; C Raskino; S Fiscus; S Pahwa; M G Fowler; S A Spector; J A Englund; C J Baker
Journal:  JAMA       Date:  1998-03-11       Impact factor: 56.272

7.  Patterns of antibody reactivity to selected human immunodeficiency virus type 1 (HIV-1) gp160 epitopes infected individuals grouped according to CD4+ cell levels.

Authors:  R Q Warren; H Wolf; R A Zajac; R N Boswell; P Kanda; R C Kennedy
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

8.  Pattern of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type 1 (HIV-1) infection.

Authors:  A De Rossi; C Zanotto; F Mammano; L Ometto; A Del Mistro; L Chieco-Bianchi
Journal:  AIDS Res Hum Retroviruses       Date:  1993-03       Impact factor: 2.205

9.  Ontogeny of anti-human immunodeficiency virus (HIV) antibody production in HIV-1-infected infants.

Authors:  H Pollack; M X Zhan; T Ilmet-Moore; K Ajuang-Simbiri; K Krasinski; W Borkowsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

10.  HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy.

Authors:  L Morris; J M Binley; B A Clas; S Bonhoeffer; T P Astill; R Kost; A Hurley; Y Cao; M Markowitz; D D Ho; J P Moore
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  4 in total

1.  An HIV-1 Broadly Neutralizing Antibody from a Clade C-Infected Pediatric Elite Neutralizer Potently Neutralizes the Contemporaneous and Autologous Evolving Viruses.

Authors:  Harekrushna Panda; Muzamil Ashraf Makhdoomi; Nitesh Mishra; Sanjeev Kumar; Haaris Ahsan Safdari; Himanshi Chawla; Heena Aggarwal; Elluri Seetharami Reddy; Rakesh Lodha; Sushil Kumar Kabra; Anmol Chandele; Somnath Dutta; Kalpana Luthra
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Viral Characteristics Associated with Maintenance of Elite Neutralizing Activity in Chronically HIV-1 Clade C-Infected Monozygotic Pediatric Twins.

Authors:  Nitesh Mishra; Muzamil Ashraf Makhdoomi; Shaifali Sharma; Sanjeev Kumar; Ayushman Dobhal; Deepshikha Kumar; Himanshi Chawla; Ravinder Singh; Uma Kanga; Bimal Kumar Das; Rakesh Lodha; Sushil K Kabra; Kalpana Luthra
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

3.  Mutations in the reverse transcriptase and protease genes of human immunodeficiency virus-1 from antiretroviral naïve and treated pediatric patients.

Authors:  Dinesh Bure; Muzamil A Makhdoomi; Rakesh Lodha; Somi Sankaran Prakash; Rajesh Kumar; Hilal A Parray; Ravinder Singh; Sushil K Kabra; Kalpana Luthra
Journal:  Viruses       Date:  2015-02-10       Impact factor: 5.048

4.  CD4-Binding Site Directed Cross-Neutralizing scFv Monoclonals from HIV-1 Subtype C Infected Indian Children.

Authors:  Sanjeev Kumar; Rajesh Kumar; Lubina Khan; Muzamil Ashraf Makhdoomi; Ramachandran Thiruvengadam; Madhav Mohata; Mudit Agarwal; Rakesh Lodha; Sushil Kumar Kabra; Subrata Sinha; Kalpana Luthra
Journal:  Front Immunol       Date:  2017-11-15       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.